论文部分内容阅读
目的探究缩宫素及米索前列醇在预防产后出血中的临床应用效果。方法 102例产妇,随机分成观察组和对照组,各51例。观察组通过缩宫素和米索前列醇治疗,对照组采取缩宫素治疗,对比两组产妇产后出血预防的情况。结果观察组产妇用药后10、20、30 min宫缩强度显著优于对照组,同时产后出血情况优于对照组(P<0.05)。结论产妇通过缩宫素联合米索前列醇预防产后出血,临床效果较好,值得临床深入推广。
Objective To investigate the clinical effect of oxytocin and misoprostol in preventing postpartum hemorrhage. Methods 102 cases of maternal women were randomly divided into observation group and control group, 51 cases each. The observation group was treated with oxytocin and misoprostol, while the control group was treated with oxytocin. The prevention of postpartum hemorrhage was compared between the two groups. Results The uterine contractility of the observation group was significantly better than that of the control group at 10, 20, 30 min after administration, and the postpartum hemorrhage was better than the control group (P <0.05). Conclusion Maternal oxytocin combined with misoprostol to prevent postpartum hemorrhage, the clinical effect is good, it is worth clinical in-depth promotion.